JAK2 and prostate carcinoma: No further data are published on Δ1–9 in breast cancer, however it has been shown to induce apoptosis in prostate cancer cell lines by antagonising autocrine prolactin-mediated janus kinase 2 (JAK2)/STAT5A/B signalling [24].